Winslow Capital Management
BIIB icon

Winslow Capital Management’s Biogen BIIB Stock Holding History

Winslow Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4
Closed -$1K – 92
2018
Q1 		$1K Sell
4
-742,654
-100% -$231M ﹤0.01% 87
2017
Q4 		$237M Buy
742,658
+59,986
+9% +$19.2M 1.3% 33
2017
Q3 		$214M Sell
682,672
-43,722
-6% -$12.9M 1.15% 42
2017
Q2 		$197M Sell
726,394
-535,923
-42% -$142M 1.05% 47
2017
Q1 		$345M Buy
+1,262,317
New +$357M 1.65% 21
2015
Q3 		– Sell
-1,288,414
Closed -$520M – 70
2015
Q2 		$520M Sell
1,288,414
-613,914
-32% -$246M 1.73% 20
2015
Q1 		$803M Sell
1,902,328
-7,669
-0.4% -$3.02M 2.48% 8
2014
Q4 		$648M Sell
1,909,997
-122,924
-6% -$39.8M 2% 12
2014
Q3 		$673M Buy
2,032,921
+448,213
+28% +$148M 2.06% 13
2014
Q2 		$500M Sell
1,584,708
-536,290
-25% -$161M 1.52% 22
2014
Q1 		$649M Sell
2,120,998
-426,291
-17% -$135M 2.03% 12
2013
Q4 		$712M Sell
2,547,289
-74,286
-3% -$19.2M 2.1% 12
2013
Q3 		$631M Sell
2,621,575
-527,604
-17% -$118M 2.05% 12
2013
Q2 		$678M Buy
+3,149,179
New +$673M 2.21% 10

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winslow Capital Management's BIIB Position: Q2 2018 in Review

Winslow Capital Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 4 shares — an estimated $1K sold.

Winslow Capital Management first reported a position in BIIB in Q2 2013 and held it in 14 quarters. The position peaked at $803M in Q1 2015. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

  • Winslow Capital Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
  • Winslow Capital Management sold 4 Biogen shares in Q2 2018, an estimated $1K.
  • Winslow Capital Management first reported a position in Biogen in Q2 2013 and held it in 14 quarters.
  • Winslow Capital Management's Biogen position peaked at $803M in Q1 2015.
  • 1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Winslow Capital Management's 13F filing for Q2 2018, filed 13 Aug 2018.